StockData
Intellia Therapeutics, Inc. logo

Intellia Therapeutics, Inc. (NTLA) dividend history

NTLANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/307% above fair value
$9.78−0.08 (-0.81%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Dividends

Intellia Therapeutics has not reported a dividend

No dividend per share appears in Intellia Therapeutics's annual filings since fiscal 2014.

See a number that looks wrong?